Physician
Oncology
Dr. Veena P. Charu, MD
|
|
Give Review
Doctor Veena P. Charu, MD practices Oncology. She attended Government Medical College Nagpur. She has 1 awards "Meaningful Use Stage 1 Certification". Veena Charu is a published doctor and has 18 publications published. The lastest was: 'Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens.' She accepts Medicare.
Publications
- Community-Based Phase IIIB Trial of Three UPFRONT Bortezomib-Based Myeloma Regimens.
- A phase 3 trial of armodafinil for the treatment of Cancer-related fatigue for patients with multiple myeloma.
- Changes in 18F-fluorodeoxyglucose and 18F-fluorodeoxythymidine positron emission tomography imaging in patients with non-small cell lung Cancer treated with erlotinib.
- TROPICS 1: a phase III, randomized, double-blind, placebo-controlled study of tenecteplase for restoration of function in dysfunctional central venous catheters.
- Randomized, double-blind, placebo-controlled trial of every-3-week darbepoetin alfa 300 micrograms for treatment of chemotherapy-induced Anemia.
- Initiation of epoetin-alpha therapy at a starting dose of 120,000 units once every 3 weeks in patients with Cancer receiving chemotherapy: an open-label, multicenter s...
- Elderly Cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim.
- A randomized, open-label, multicenter trial of immediate versus delayed intervention with darbepoetin alfa for chemotherapy-induced Anemia.
- Efficacy and safety of every-2-week darbepoetin alfa in patients with anemia of Cancer: a controlled, randomized, open-label phase II trial.
- Combination therapy for chemotherapy-induced nausea and vomiting in patients receiving moderately emetogenic chemotherapy: palonosetron, dexamethasone, and aprepitant.
- Randomized, open-label comparison of epoetin alfa extended dosing (80 000 U Q2W) vs weekly dosing (40 000 U QW) in patients with chemotherapy-induced Anemia.
- Treatment of chemotherapy-induced anemia in breast Cancer: results of a randomized controlled trial of darbepoetin alfa 200 microg every 2 weeks versus epoetin alfa 40...
- Randomized comparison of epoetin alfa (40,000 U weekly) and darbepoetin alfa (200 microg every 2 weeks) in anemic patients with Cancer receiving chemotherapy.
- A randomized comparison of every-2-week darbepoetin alfa and weekly epoetin alfa for the treatment of chemotherapy-induced Anemia in patients with breast, lung, or gyn...
- Assessment of hematologic effects and fatigue in Cancer patients with chemotherapy-induced anemia given darbepoetin alfa every two weeks.
- Improved prevention of moderately emetogenic chemotherapy-induced nausea and vomiting with palonosetron, a pharmacologically novel 5-HT3 receptor antagonist: results o...
- Every-2-week darbepoetin alfa is comparable to rHuEPO in treating chemotherapy-induced anemia. Results of a combined Analysis.
Schools
Government Medical College Nagpur Maharashtra University Of Health Sciences
Bergen Pines Co Med Center
Westchester Co Med Center
New York Med College
Procedures Preformed
- Cardiac MRI (Magnetic Resonance Imaging) of Heart or Chest
- Plasmapheresis
- Thoracentesis
Conditions Treated
- Acute Leukemia
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- View All
Doctors Specialties
- Hematology
- Medical Oncology
- Oncology
Accepted Insurances
Awards
- Meaningful Use Stage 1 Certification
Education
-
Government Medical College Nagpur
Drug Facts
| NPI NUMBER | 1568438976 | |
| NPPES Provider LastName | CHARU | |
| NPPES Provider FirstName | VEENA | |
| NPPES Provider ZIPCode | 928011830 | |
| NPPES Provider State | CA | |
| Specialty Description | Hematology/Oncology | |
| Total Claim Count | 2031.0 | |
| Distinct Opioid Count | 2.0 | |
| Opioid Claim Count | 54.0 | |
| Percent Opioid Claims | 2.66 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1568438976 |
| Last Name Of The Provider | CHARU |
| First Name Of The Provider | VEENA |
| View All |
Similar Doctors
|
Dr. Kambiz Afrasiabi, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Joel N. Lester, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ajit S. Maniam, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Reena K. Vora, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. David C. Choi, MD |
|
|
Dr. Daniel J. Kim, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Grace J. Young, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Wanda I. Lopez, MD |
|
|
Dr. Thomas C. Lee, MD |